Zurcher Kantonalbank (Zurich Cantonalbank) - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q1 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$32,402
-39.2%
19,1730.0%0.00%
Q2 2023$53,301
+52.7%
19,1730.0%0.00%
Q1 2023$34,895
-64.1%
19,1730.0%0.00%
-100.0%
Q4 2022$97,207
+43.0%
19,173
+39.1%
0.00%
Q3 2022$68,000
+33.3%
13,7810.0%0.00%
Q2 2022$51,000
-33.8%
13,7810.0%0.00%
Q1 2022$77,000
-29.4%
13,781
-22.9%
0.00%
-100.0%
Q4 2021$109,000
+34.6%
17,865
+115.3%
0.00%
Q3 2021$81,000
-31.4%
8,297
+0.4%
0.00%
-100.0%
Q2 2021$118,000
-39.8%
8,2680.0%0.00%0.0%
Q1 2021$196,0008,2680.00%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$4,180,0000.56%
HARBOURVEST PARTNERS LLC 335,709$2,041,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$586,0000.20%
SHEETS SMITH WEALTH MANAGEMENT 152,276$926,0000.12%
GSA CAPITAL PARTNERS LLP 129,260$786,0000.10%
Clearwater Capital Advisors, LLC 140,551$855,0000.09%
Virtus ETF Advisers LLC 28,969$176,0000.07%
XTX Topco Ltd 19,159$116,0000.07%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 49,464$301,0000.04%
Vident Investment Advisory, LLC 168,476$1,024,0000.03%
View complete list of IMMUNITYBIO INC shareholders